These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 26321738)
1. Activation of the farnesoid X receptor attenuates triptolide-induced liver toxicity. Jin J; Sun X; Zhao Z; Wang W; Qiu Y; Fu X; Huang M; Huang Z Phytomedicine; 2015 Sep; 22(10):894-901. PubMed ID: 26321738 [TBL] [Abstract][Full Text] [Related]
2. Role of Nrf2 in protection against triptolide-induced toxicity in rat kidney cells. Li J; Jin J; Li M; Guan C; Wang W; Zhu S; Qiu Y; Huang M; Huang Z Toxicol Lett; 2012 Sep; 213(2):194-202. PubMed ID: 22820427 [TBL] [Abstract][Full Text] [Related]
3. Activation of Nrf2 protects against triptolide-induced hepatotoxicity. Li J; Shen F; Guan C; Wang W; Sun X; Fu X; Huang M; Jin J; Huang Z PLoS One; 2014; 9(7):e100685. PubMed ID: 24988078 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of P-glycoprotein Gene Expression and Function Enhances Triptolide-induced Hepatotoxicity in Mice. Kong LL; Zhuang XM; Yang HY; Yuan M; Xu L; Li H Sci Rep; 2015 Jul; 5():11747. PubMed ID: 26134275 [TBL] [Abstract][Full Text] [Related]
5. Metabolic alterations in triptolide-induced acute hepatotoxicity. Zhao J; Xie C; Mu X; Krausz KW; Patel DP; Shi X; Gao X; Wang Q; Gonzalez FJ Biomed Chromatogr; 2018 Oct; 32(10):e4299. PubMed ID: 29799631 [TBL] [Abstract][Full Text] [Related]
6. Isoliquiritigenin protects against triptolide-induced hepatotoxicity in mice through Nrf2 activation. Cao L-; Yan M; Ma YX; Zhang BK; Fang PF; Xiang DX; Li ZH; Gong H; Deng Y; Li HD Pharmazie; 2016 Jul; 71(7):394-397. PubMed ID: 29441915 [TBL] [Abstract][Full Text] [Related]
7. Integrated targeted sphingolipidomics and transcriptomics reveal abnormal sphingolipid metabolism as a novel mechanism of the hepatotoxicity and nephrotoxicity of triptolide. Qu L; Qu F; Jia Z; Wang C; Wu C; Zhang J J Ethnopharmacol; 2015 Jul; 170():28-38. PubMed ID: 25978956 [TBL] [Abstract][Full Text] [Related]
8. Role of MicroRNA-155 in Triptolide-induced hepatotoxicity via the Nrf2-Dependent pathway. Li Y; Guo L; Hou Z; Gong H; Yan M; Zhang B J Ethnopharmacol; 2021 Dec; 281():114489. PubMed ID: 34363931 [TBL] [Abstract][Full Text] [Related]
9. Protective Effect of Vitamin C on Triptolide-induced Acute Hepatotoxicity in Mice through mitigation of oxidative stress. Xu P; Li Y; Yu Z; Yang L; Shang R; Yan Z An Acad Bras Cienc; 2019 Jun; 91(2):e20181257. PubMed ID: 31241707 [TBL] [Abstract][Full Text] [Related]
10. Licorice root extract and magnesium isoglycyrrhizinate protect against triptolide-induced hepatotoxicity via up-regulation of the Nrf2 pathway. Tan QY; Hu Q; Zhu SN; Jia LL; Xiao J; Su HZ; Huang SY; Zhang J; Jin J Drug Deliv; 2018 Nov; 25(1):1213-1223. PubMed ID: 29791258 [TBL] [Abstract][Full Text] [Related]
11. Circadian clock regulates hepatotoxicity of Tripterygium wilfordii through modulation of metabolism. Zhao H; Tong Y; Lu D; Wu B J Pharm Pharmacol; 2020 Dec; 72(12):1854-1864. PubMed ID: 32478421 [TBL] [Abstract][Full Text] [Related]
12. Catalpol coordinately regulates phase I and II detoxification enzymes of Triptolide through CAR and NRF2 pathways to reduce Triptolide-induced hepatotoxicity. Fu L; Zhou L; Geng S; Li M; Lu W; Lu Y; Feng Z; Zhou X Biomed Pharmacother; 2020 Sep; 129():110379. PubMed ID: 32563148 [TBL] [Abstract][Full Text] [Related]
13. Quantitative Proteomics and Targeted Fatty Acids Analysis Reveal the Damage of Triptolide in Liver and Kidney. Li M; Hu T; Tie C; Qu L; Zheng H; Zhang J Proteomics; 2017 Nov; 17(22):. PubMed ID: 28895652 [TBL] [Abstract][Full Text] [Related]
14. The research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticle. Mei Z; Li X; Wu Q; Hu S; Yang X Pharmacol Res; 2005 Apr; 51(4):345-51. PubMed ID: 15683748 [TBL] [Abstract][Full Text] [Related]
15. Knockout of hepatic P450 reductase aggravates triptolide-induced toxicity. Xue X; Gong L; Qi X; Wu Y; Xing G; Yao J; Luan Y; Xiao Y; Li Y; Wu X; Chen M; Gu J; Ren J Toxicol Lett; 2011 Aug; 205(1):47-54. PubMed ID: 21596114 [TBL] [Abstract][Full Text] [Related]
16. Farnesoid X receptor antagonizes JNK signaling pathway in liver carcinogenesis by activating SOD3. Wang YD; Chen WD; Li C; Guo C; Li Y; Qi H; Shen H; Kong J; Long X; Yuan F; Wang X; Huang W Mol Endocrinol; 2015 Feb; 29(2):322-31. PubMed ID: 25496033 [TBL] [Abstract][Full Text] [Related]
17. FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation. Yao J; Zhou CS; Ma X; Fu BQ; Tao LS; Chen M; Xu YP World J Gastroenterol; 2014 Oct; 20(39):14430-41. PubMed ID: 25339829 [TBL] [Abstract][Full Text] [Related]
18. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β. Noh K; Kim YM; Kim YW; Kim SG Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890 [TBL] [Abstract][Full Text] [Related]
19. Autophagy in Triptolide-Mediated Cytotoxicity in Hepatic Cells. Wei YM; Luan ZH; Liu BW; Wang YH; Chang YX; Xue HQ; Ren JH Int J Toxicol; 2019; 38(5):436-444. PubMed ID: 31342801 [TBL] [Abstract][Full Text] [Related]
20. Triptolide impairs thioredoxin system by suppressing Notch1-mediated PTEN/Akt/Txnip signaling in hepatocytes. Shen F; Xiong Z; Kong J; Wang L; Cheng Y; Jin J; Huang Z Toxicol Lett; 2019 Jan; 300():105-115. PubMed ID: 30394310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]